For choline esterase inhibitors effects on functional and structural imaging have been reported in Alzheimer’s disease and its prestage mild cognitive impairment (Prins et al., 2014; Kim et al., 2017). This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.